- Sagliker Y, Balal M, Sagliker Ozkaynak P, et al. Sagliker syndrome: uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure. Semin Nephrol. 2004;24:449–455. doi: 10.1016/j.semnephrol.2004.06.021.
- Lee VS, Webb MS Jr, Martinez S, et al. Uremic leontiasis ossea: “bighead” disease in humans? Radiologic, clinical, and pathologic features. Radiology. 1996;199:233–240. doi: 10.1148/radiology.199.1.8633151.
- Demirhan O, Arslan A, Sagliker Y, et al. Gene mutations in chronic kidney disease patients with secondary hyperparathyroidism and Sagliker syndrome. J Ren Nutr. 2015;25:76–186.
- Shakeri S, Zarehparvar Moghadam S, Sadeghi R, Ayati N. Sagliker syndrome in a patient with secondary hyperparathyroidism and chronic renal insufficiency: a case report. Asia Ocean J Nucl Med Biol. 2018;6:167–170.
- Cholakova R, Pechalova P, Kapon E. Sagliker syndrome: first four cases in Bulgaria. G Ital Nefrol. 2016;33:1724–5590.
- Akkas BE, Demirel BB, Unlu EN, et al. A rare case describing catastrophic destruction of the whole skeleton caused by severe hyperparathyroidism. BMJ Case Rep. 2015;bcr2015211796.
- Yildiz I, Sagliker Y, Demirhan O, et al. International evaluation of unrecognizably uglifying human faces in late and severe secondary hyperparathyroidism in chronic kidney disease. Sagliker syndrome. A unique catastrophic entity, cytogenetic studies for chromosomal abnormalities, calcium-sensing receptor gene and GNAS1 mutations. Striking and promising missense mutations on the GNAS1 gene exons 1, 4, 10, 4. J Ren Nutr. 2012;22:157–164. doi: 10.1053/j.jrn.2011.10.030.
- Chen XH, Shen B, Zou JZ, et al. Clinical status of Sagliker syndrome: a case report and literature review. Ren Fail. 2014;36:800–803. doi: 10.3109/0886022X.2014.890110.
- Sagliker Y, Acharya V, Golea O, et al. Is survival enough for quality of life in Sagliker syndrome—uglifying human face appearances in chronic kidney disease? J Nephrol. 2008;21(Suppl 13):S134–S138.
Sagliker syndrome in a patient with end-stage renal disease with secondary hyperparathyroidism
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.